Mumbai, November 27 (Udaipur Kiran): Shares of Glenmark Pharmaceuticals were trading higher on the BSE after the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the United States Food & Drug Administration (USFDA) for its manufacturing facility in the USA. The stock was trading at Rs. 1,941.90, up […]